Recently, the assessment of phosphatase and tensin homolog (PTEN) expression, a key tumor suppressor gene mainly involved in DNA repair, apoptosis, and cell survival, was suggested as a complementary biomarker to pre-screen MMR status in breast cancer [30, 68]. This evidence concerns the gene PTEN and breast carcinoma.